Antithyroid and myelotoxic drugs increase the likelihood of developing agranulocytosis, the latter, in addition - thrombocytopenia.
Izidakamizwa ze-Antithyroid nezangu-myelotoxic zandisa amathuba okukhula kwe-agranulocytosis, owokugcina, ngaphezu kwalokho - i-thrombocytopenia.